All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
PRIME MEDICINE, INC. Last Reported: 5/31/2024 Stock Symbol: PRME

Business Address

21 ERIE ST.

CAMBRIDGE , MA US 02139

Mailing Address

21 ERIE ST.

CAMBRIDGE , MA US 02139
Phone Number: 617-465-0013 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020
Cash and Cash Equivalents $94,162,000.00 $41,574,000.00 $43,959,000.00 $120,577,000.00 $133,462,000.00 $187,620,000.00 $47,947,000.00 -- -- $185,420,000.00 $200,664,000.00 -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- $19,214,000.00 $10,872,000.00 $3,982,000.00 $2,697,000.00 $2,180,000.00 -- -- $959,000.00 -- -- -- --
Total Current Assets $217,654,000.00 $142,976,000.00 $184,531,000.00 $218,490,000.00 $253,500,000.00 $296,618,000.00 $148,845,000.00 -- -- $270,579,000.00 -- -- -- --
Property Plant and Equipement $23,926,000.00 $22,659,000.00 $22,032,000.00 $20,558,000.00 $21,590,000.00 $19,009,000.00 $14,967,000.00 -- -- $4,932,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $779,000.00 $779,000.00 $1,816,000.00 $1,816,000.00 $1,646,000.00 $1,646,000.00 $5,613,000.00 -- -- $2,474,000.00 -- -- -- --
Total Assets $311,383,000.00 $193,851,000.00 $239,145,000.00 $280,865,000.00 $316,946,000.00 $360,314,000.00 $215,265,000.00 -- -- $301,856,000.00 -- -- -- --
Accounts Payable $10,078,000.00 $19,537,000.00 $14,124,000.00 $5,490,000.00 $4,561,000.00 $4,332,000.00 $4,111,000.00 -- -- $1,435,000.00 -- -- -- --
Accrued Liabilities $7,612,000.00 $14,110,000.00 $14,023,000.00 -- $7,543,000.00 $10,688,000.00 $6,530,000.00 -- -- $37,192,000.00 -- -- -- --
Total Current Liabilities $67,617,000.00 $60,780,000.00 $45,188,000.00 $40,763,000.00 $38,145,000.00 $44,044,000.00 $42,561,000.00 -- -- $62,296,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-95,000.00 $-15,000.00 $-149,000.00 $-268,000.00 $-205,000.00 $-384,000.00 $-454,000.00 -- -- $-27,000.00 -- -- -- --
Accumulated Deficit $-537,100,000.00 $-491,330,000.00 $-425,700,000.00 $-374,979,000.00 $-332,600,000.00 $-293,200,000.00 $-253,900,000.00 -- -- $-171,376,000.00 -- -- -- --
Total Stockholders' Equity $243,766,000.00 $133,071,000.00 $193,957,000.00 $240,102,000.00 $278,801,000.00 $316,270,000.00 $-223,096,000.00 $-195,063,000.00 $-166,942,000.00 $-156,240,000.00 $-94,418,000.00 $-78,370,000.00 $-85,310,000.00 $2,338,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $311,383,000.00 $193,851,000.00 $239,145,000.00 $280,865,000.00 $316,946,000.00 $360,314,000.00 $215,265,000.00 -- -- $301,856,000.00 -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $37,774,000.00 $147,905,000.00 -- -- $30,880,000.00 $86,725,000.00 $57,664,000.00 -- -- -- $17,661,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $48,932,000.00 $204,792,000.00 $51,459,000.00 $45,257,000.00 $40,033,000.00 $116,544,000.00 $31,655,000.00 -- -- -- $10,427,000.00 -- -- --
Loss from Operations $-48,341,000.00 $-204,792,000.00 $-136,749,000.00 $-85,290,000.00 $-40,033,000.00 $-116,544,000.00 $-77,858,000.00 -- -- -- $-24,398,000.00 -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.44 $-2.18 $-1.46 $-0.91 $-0.44 $-4.19 $-4.91 -- -- -- $-1.52 -- -- --
Weighted Average Shares Basic 104,466,178 90,969,327 90,469,866 90,467,298 89,064,895 33,891,264 20,665,225 -- -- -- 11,795,738 -- -- --
Earnings Per Share Diluted $-0.44 $-2.18 $-1.46 $-0.91 $-0.44 $-4.19 $-4.91 -- -- -- $-9.74 -- -- --
Weighted Average Shares Diluted 104,466,178 90,969,327 90,469,866 90,467,298 89,064,895 33,891,264 20,665,225 -- -- -- 11,795,738 -- -- --
Common Stock Shares Authorized 775,000,000 775,000,000 775,000,000 775,000,000 775,000,000 775,000,000 293,258,790 -- -- 293,258,790 -- -- -- --
Common Stock Shares Outstanding 120,021,274 97,377,121 97,324,301 97,269,915 97,227,809 97,209,213 33,559,912 -- -- 32,413,860 -- -- -- --
Common Stock Value $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- $0.00 -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com